{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:58:17Z","timestamp":1786121897608,"version":"build-2736575974"},"reference-count":61,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR201165"],"award-info":[{"award-number":["NIHR201165"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      Young adults (aged \u2264\u200940\u2009years) are underrepresented in clinical trials that investigate interventions for those living with Type 2 diabetes (T2D). This study evaluated the efficacy of semaglutide treatment in young adults with T2D by examining the effects on HbA\n                      <jats:sub>1c<\/jats:sub>\n                      and body weight (BW) during the SUSTAIN and PIONEER programmes compared to placebo and active comparators, according to age at study enrolment. This study also assessed aggregated safety data across age subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      This\n                      <jats:italic>post hoc<\/jats:italic>\n                      analysis of the SUSTAIN (once\u2010weekly subcutaneous administration) and PIONEER (once\u2010daily oral administration) programmes assessed the efficacy of semaglutide treatment in different age subgroups by comparing change in HbA\n                      <jats:sub>1c<\/jats:sub>\n                      and BW between young adults with T2D (\u2264\u200940\u2009years), middle\u2010aged adults with T2D (&gt;\u200940\u2010\u2009\u2264\u200950\u2009years), and middle older\u2010aged adults with T2D (&gt;\u200950\u2009years). Selected safety outcomes were assessed, focusing on serious adverse events (SAEs) and gastrointestinal SAEs from the programmes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Findings indicate a reduction in HbA\n                      <jats:sub>1c<\/jats:sub>\n                      levels and BW in participants across all age subgroups that were treated with semaglutide, particularly in young adults versus other age subgroups. The proportion of participants experiencing SAEs was overall comparable between semaglutide treatment and comparators across age subgroups and administration route.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Semaglutide shows notable and consistent efficacy in reducing HbA\n                      <jats:sub>1c<\/jats:sub>\n                      and BW across all age subgroups with T2D, including young adults. Effective glucose\u2010 and weight\u2010lowering interventions in people living with T2D at an earlier stage in life may reduce the high risk of future health complications associated with developing T2D as a younger adult.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.70770","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:52:51Z","timestamp":1776419571000},"page":"5787-5802","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the\n                    <scp>SUSTAIN<\/scp>\n                    and\n                    <scp>PIONEER<\/scp>\n                    Clinical Trials"],"prefix":"10.1111","volume":"28","author":[{"given":"Francesco","family":"Zaccardi","sequence":"first","affiliation":[{"name":"Leicester Real World Evidence Unit, Diabetes Research Centre University of Leicester  Leicester UK"},{"name":"Diabetes Research Centre University of Leicester  Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7706-4585","authenticated-orcid":false,"given":"Vanita R.","family":"Aroda","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital, Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecenur Guder","family":"Arslan","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  S\u00f8borg Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bardtrum","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  S\u00f8borg Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-8296","authenticated-orcid":false,"given":"Jonathan","family":"Goldney","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre University of Leicester  Leicester UK"},{"name":"NIHR Leicester Biomedical Research Centre University Hospitals of Leicester NHS Trust  Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ising","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S  S\u00f8borg Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Priyadarshini","sequence":"additional","affiliation":[{"name":"Novo Nordisk GBS  Bengaluru India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Slater","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre University of Leicester  Leicester UK"},{"name":"NIHR Leicester Biomedical Research Centre University Hospitals of Leicester NHS Trust  Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre University of Leicester  Leicester UK"},{"name":"NIHR Leicester Biomedical Research Centre University Hospitals of Leicester NHS Trust  Leicester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"International Diabetes Federation \u201cIDF Diabetes Atlas 11th Edition \u201dhttps:\/\/diabetesatlas.org\/."},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(22)01655\u20105"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125\u2010020\u201005174\u20109"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(17)30186\u20109"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(25)00830\u2010X"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(24)00242\u20100"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109333"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0690"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.70081"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1994.tb00355.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(14)70137\u20108"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010019\u201000720\u20100"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2022.1501"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(23)00225\u20105"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc22\u20101237"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300\u2010015\u20100118\u2010y"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464\u20105491.2008.02533.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc26\u2010S009"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125\u2010022\u201005787\u20102"},{"key":"e_1_2_9_22_1","unstructured":"National Institute of Health and Care Excellence \u201cNICE Guideline (NG28) Type 2 Diabetes in Adults: Management [cited 2026 April] \u201dhttps:\/\/www.nice.org.uk\/guidance\/ng28\/chapter\/Recommendations."},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901118"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2501006"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(17)30013\u2010X"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(17)30092\u2010X"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17\u20100417"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(17)30085\u20102"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018\u201000070"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13082"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13218"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(18)30024\u2010X"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(19)30066\u2010X"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.101117"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14232"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(19)30194\u20109"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19\u20100749"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19\u20100898"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(19)31271\u20101"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19\u20100883"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003316"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125\u2010020\u201005319\u2010w"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2025.0561"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23\u20102356"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019\u20105154.185700"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1671965"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2019.12.006"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201090611\u2010x"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.037885"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(25)00509\u20104"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14373"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933\u2010022\u201001585\u20107"},{"issue":"9131","key":"e_1_2_9_55_1","first-page":"837","article-title":"UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"Intensive blood\u2010glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(24)00537\u20103"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00012.2016"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.2337\/db20\u20100602"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz072"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2020.10.002"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc15\u20100258"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70770","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.70770","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.70770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:35:10Z","timestamp":1786088110000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.onlinelibrary.wiley.com\/doi\/10.1111\/dom.70770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/dom.70770"],"URL":"https:\/\/doi.org\/10.1111\/dom.70770","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.70770\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v1\/review4","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v1\/review5","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.70770\/v1\/review1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2026-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}